“How can we continue to move T1D to the background?” Medtronic’s Dr. Jennifer McVean

This week, catching up with Medtronic’s Senior Director of Global Medical Affairs Dr. Jennifer McVean. It’s been one year since the 780G was approved in the US, what does the device - and its seven-day infusion set - look like in the real world. Plus, we have a big discussion about the future of type 1 diabetes - Dr. McVean has lead some significant trials - she lives with type 1 and has some big ideas about changes she’d like to see.
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.

Find out more about Moms' Night Out
Please visit our Sponsors & Partners - they help make the show possible!
Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com)
Omnipod - Simplify Life
Learn about Dexcom
Edgepark Medical Supplies
Check out VIVI Cap to protect your insulin from extreme temperatures
Learn more about AG1 from Athletic Greens
Drive research that matters through the T1D Exchange
The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:
Sign up for our newsletter here
Here's where to find us:
Facebook (Group)
Facebook (Page)
Instagram
Twitter
Check out Stacey's books!
Learn more about everything at our home page www.diabetes-connections.com
Reach out with questions or comments: [e-mail]

[@frankpeprah6198]

Excellent podcast we are waiting for another podcast on sernova second corhot results on her t1d patients in the April